Self-reported medication adherence and treatment satisfaction in patients with epilepsy

Epilepsy and Behavior

Volumn 21, Issue 3, 2011, Pages 301-305

  Sweileh, Waleed M ^a   Ihbesheh, Manal S ^a   Jarar, Ikhlas S ^a   Taha, Adham S Abu ^a   Sawalha, Ansam F ^a   Zyoud, Sa'ed H ^b   Jamous, Raniah M ^a   Morisky, Donald E ^c  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

^b SCHOOL OF PHYSICS   (Malaysia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Antiepileptic drug; Epilepsy; Palestine; Satisfaction

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; DISEASE DURATION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; SAMPLING; SEIZURE; SELF REPORT; STRUCTURED QUESTIONNAIRE; THERAPY EFFECT; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTICONVULSANTS; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; SELF REPORT; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 79959575552     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.04.011     Document Type: Article

References (46)

1. World Health Organization Epilepsy in the WHO Eastern Mediterranean region: bridging the gap Available at:, Accessed: January 23, 2011. http://www.emro.who.int/dsaf/dsa1039.pdf.
2. World Health Organization Epilepsy: fact sheet Available at:, Accessed January 23, 2011. http://www.who.int/mediacentre/factsheets/fs999/en/.
3. Shinnar S., Berg A.T. Does antiepileptic drug therapy prevent the development of "chronic" epilepsy?. Epilepsia 1996, 37:701-708.
4. Devinsky O. Patients with refractory seizures. N Engl J Med 1999, 340:1565-1570.
5. Manjunath R., Davis K.L., Candrilli S.D., Ettinger A.B. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav 2009, 14:372-378.
6. Hovinga C.A., Asato M.R., Manjunath R., et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008, 13:316-322.
7. Davis K.L., Candrilli S.D., Edin H.M. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia 2008, 49:446-454.
8. Rosenfeld W.E., Bramley T.J., Meyer K.L. Patient compliance with topiramate vs. other antiepileptic drugs: a claims database analysis. Epilepsia 2004, 45:238.
9. Cramer J.A., Glassman M., Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002, 3:338-342.
10. Faught R.E., Weiner J.R., Guerin A., Cunnington M.C., Duh M.S. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia 2009, 50:501-509.
11. Buck D., Jacoby A., Baker G.A., Chadwick D.W. Factors influencing compliance with antiepileptic drug regimes. Seizure 1997, 6:87-93.
12. Doughty J., Baker G.A., Jacoby A., Lavaud V. Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy. Epilepsy Behav 2003, 4:710-716.
13. Garnett W.R. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 2000, 20. 191-9S.
14. Parkerson K., Pathmanathan J., Milligan T. Optimizing antiepileptic treatment. J Clin Outcomes Manag 2009, 16:468-480.
15. Eatock J., Baker G.A. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat 2007, 3:117-131.
16. Loiseau P., Marchal C. Determinants of compliance in epileptic patients. Epilepsy Res Suppl 1988, 1:135-140.
17. Dunbar-Jacob J., Mortimer-Stephens M.K. Treatment adherence in chronic disease. J Clin Epidemiol 2001, 54(Suppl. 1):S57-S60.
18. Cramer J., Vachon L., Desforges C., Sussman N.M. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995, 36:1111-1117.
19. Straka R.J., Fish J.T., Benson S.R., Suh J.T. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy 1997, 17:126-132.
20. George C.F., Peveler R.C., Heiliger S., Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000, 50:166-171.
21. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
22. Llewellyn-Thomas H.A. Investigating patients' preferences for different treatment options. Can J Nurs Res 1997, 29:45-64.
23. Schommer J.C., Kucukarslan S.N. Measuring patient satisfaction with pharmaceutical services. Am J Health Syst Pharm 1997, 54:2721-2732. quiz 2741-3.
24. Dunbar-Jacob J., Erlen J.A., Schlenk E.A., Ryan C.M., Sereika S.M., Doswell W.M. Adherence in chronic disease. Annu Rev Nurs Res 2000, 18:48-90.
25. Gomes Mda M., Maia Filho Hde S., Noe R.A. Anti-epileptic drug intake adherence: the value of the blood drug level measurement and the clinical approach. Arq Neuropsiquiatr 1998, 56:708-713.
26. Schmidt D., Reininghaus R., Winkel R. Relevance of poor compliance for seizure control. Epilepsy Res Suppl 1988, 1:141-146.
27. Peterson G.M., McLean S., Millingen K.S. Determinants of patient compliance with anticonvulsant therapy. Epilepsia 1982, 23:607-613.
28. Long L., Reeves A.L., Moore J.L., Roach J., Pickering C.T. An assessment of epilepsy patients' knowledge of their disorder. Epilepsia 2000, 41:727-731.
29. Ismail H., Wright J., Rhodes P., Small N. Religious beliefs about causes and treatment of epilepsy. Br J Gen Pract 2005, 55:26-31.
30. Morisky D.E., Ang A., Krousel-Wood M., Ward H.J. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008, 10:348-354.
31. Bharmal M., Payne K., Atkinson M.J., Desrosiers M.P., Morisky D.E., Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes 2009, 7:36.
32. Atkinson M.J., Kumar R., Cappelleri J.C., Hass S.L. Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM version II) among outpatient pharmacy consumers. Value Health 2005, 8(Suppl. 1):S9-S24.
33. Atkinson M.J., Sinha A., Hass S.L., et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004, 2:12.
34. McAuley J.W., McFadden L.S., Elliott J.O., Shneker B.F. An evaluation of self-management behaviors and medication adherence in patients with epilepsy. Epilepsy Behav 2008, 13:637-641.
35. Jones R.M., Butler J.A., Thomas V.A., Peveler R.C., Prevett M. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 2006, 15:504-508.
36. Lusic I., Titlic M., Eterovic D. Epileptic patient compliance with prescribed medical treatment. Acta Med Croat 2005, 59:13-18.
37. Asawavichienjinda T., Sitthi-Amorn C., Tanyanont W. Compliance with treatment of adult epileptics in a rural district of Thailand. J Med Assoc Thai 2003, 86:46-51.
38. Yeager K.A., Diiorio C., Shafer P.O., et al. The complexity of treatments for persons with epilepsy. Epilepsy Behav 2005, 7:679-686.
39. Baker G.A., Jacoby A., Buck D., Stalgis C., Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997, 38:353-362.
40. Stanaway L., Lambie D.G., Johnson R.H. Non-compliance with anticonvulsant therapy as a cause of seizures. NZ Med J 1985, 98:150-152.
41. Shope J.T. Compliance in children and adults: review of studies. Epilepsy Res Suppl 1988, 1:23-47.
42. Hayden M., Penna C., Buchanan N. Epilepsy: patient perceptions of their condition. Seizure 1992, 1:191-197.
43. Ross J., Stefan H., Schauble B., Day R., Sander J.W. European survey of the level of satisfaction of patients and physicians in the management of epilepsy in general practice. Epilepsy Behav 2010, 19:36-42.
44. Viteri C., Codina M., Cobaleda S., Lahuerta J., Barriga J., Morales M.D. Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine or valproic acid. Seizure 2010, 19:432-438.
45. Bautista R.E., Glen E.T., Shetty N.K. Factors associated with satisfaction with care among patients with epilepsy. Epilepsy Behav 2007, 11:518-524.
46. Modi A.C., Guilfoyle S.M., Morita D.A., Glauser T.A. Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy. Epilepsia 2011, 52:370-376.